About this trial
This study evaluates the inter-observer reliability of a standardized WB-MRI scoring system for CRMO and its consistency with the PedCNO clinical score. It also investigates whether changes in the radiologic score mirror therapeutic response, supporting a more objective clinical-radiological disease assessment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with a diagnosis of CRMO according to the international Bristol clinical and radiologic criteria, followed at the Pediatric Rheumatology Clinic of the Pediatric Unit, IRCCS AOU Bologna, Sant'Orsola Hospital;
Age under 18 years at the time of CRMO diagnosis;
At least one WB-MRI performed as part of routine clinical follow-up between January 2015 and the start date of the study;
Availability of complete clinical documentation (including reports, radiologic images, and clinical information) sufficient to apply both the WB-MRI score and the PedCNO score;
Disqualifiers
None
Trial population
Patients with a diagnosis of pediatric-onset CRMO and at least one WB-MRI performed between January 2015 and the start date of the study, followed at the Pediatric Rheumatology Clinic of the Pediatric Unit, IRCCS AOU Bologna, Sant'Orsola Hospital
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
To assess the inter-observer reliability and reproducibility of the WB-MRI radiologic scoring system for CRMO lesions, applied independently and in a blinded manner by at least two pediatric radiologists for each WB-MRI performed in patients in with CRMO
Inter-observer agreement for each individual examination, calculated using ICC
Secondary outcomes
To evaluate the clinical-radiological correlation between the WB-MRI radiologic score and the PedCNO clinical score
WB-MRI score AND PedCNO score
Sponsors and contacts
Click on the lead sponsor to view all of their trials.